FdaApplication
NDA 021903
Identifiers
- fda_app_no: NDA021903
Properties
| Property | Value |
|---|---|
| applicant_name | RECORDATI RARE DISEASES INC |
| application_type | NDA |
| approval_date | 2006-04-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEOPROFEN | IBUPROFEN LYSINE | EQ 20MG BASE/2ML (EQ 10MG BASE/ML) | INJECTABLE;INTRAVENOUS |
1 product